The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Heterozygous activating mutation in RAC2 causes infantile-onset combined immunodeficiency with susceptibility to viral infections
Abstract
Here we describe a 10-year-old girl with combined immunodeficiency presenting as recurring chest infections, lung disease and herpetic skin infections. The patient experienced two hematopoietic stem cell transplantations and despite full chimerism, she developed bone marrow aplasia due to adenovirus infection and died at post-transplant day 86. Immunologic investigation revealed low numbers of TRECs/KRECs, a severe reduction of memory B cells, absence of isohemagglutinins, and low IgG levels. Whole exome sequencing (WES) identified a novel heterozygous mutation in RAC2(c.275A > C, p.N92 T). Flow cytometric investigation of neutrophil migration demonstrated an absence of chemotaxis to fMLP. Cell lines transfected with RAC2 [N92 T] displayed characteristics of active GTP-bound RAC2 including enhanced NADPH oxidase-derived superoxide production both at rest and in response to PMA. Our findings broaden the clinical picture of RAC2 dysfunction, showing that some individuals can present with a combined immunodeficiency later in childhood rather than a congenital neutrophil disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is noteworthy that this mutation differed from the loss-offunction (LOF) or gain-of-function (GOF) mutations (Online Supplementary Figure S1A) previously reported as being responsible for mild neutrophil defects and/or lymphopenia. 15-20”
From A gain-of-function RAC2 mutation is associated with bone-marrow hypoplasia and an autosomal dominant form of severe combined immunodeficiency (2020) · cites this paper as [20]
Citations
Cites
Dominant activating RAC2 mutation with lymphopenia, immunodeficiency, and cytoskeletal defects
Hsu, A. P., Donkó, A., Arrington, M. E., Swamydas, M., Fink, D., Das, A., Escobedo, O., Bonagura, V., Szabolcs, P., Steinberg, H. N., et al. (2019) · Blood · doi:10.1182/blood-2018-11-886028 · Cited by 92
Self-citation
Research works printed but not linked: 10
- Petri, 2018, Neutrophil chemotaxis, Cell Tissue Res., 371, 425, 10.1007/s00441-017-2776-8 · DOI · Paper page
- Routes, 2009, Statewide newborn screening for severe T-cell lymphopenia, Jama, 302, 2465, 10.1001/jama.2009.1806 · DOI · Paper page
- Knaus, 1991, Regulation of phagocyte oxygen radical production by the GTP-binding protein Rac 2, Science, 254, 1512, 10.1126/science.1660188 · DOI · Paper page
- Fattouh, 2013, Rac2-deficiency leads to exacerbated and protracted colitis in response to Citrobacter rodentium infection, PLoS One, 8, 10.1371/journal.pone.0061629 · DOI
- Ambruso, 2000, Human neutrophil immunodeficiency syndrome is associated with an inhibitory Rac2 mutation, Proc. Natl. Acad. Sci. U. S. A., 97, 4654, 10.1073/pnas.080074897 · DOI · Paper page
- Kurkchubasche, 2001, Clinical features of a human Rac2 mutation: a complex neutrophil dysfunction disease, J. Pediatr., 139, 141, 10.1067/mpd.2001.114718 · DOI · Paper page
- Williams, 2000, Dominant negative mutation of the hematopoietic-specific rho GTPase, Rac2, is associated with a human phagocyte immunodeficiency, Blood, 96, 1646
- Alkhairy, 2015, RAC2 loss-of-function mutation in 2 siblings with characteristics of common variable immunodeficiency, The Journal of allergy and clinical immunology., 135, 1380, 10.1016/j.jaci.2014.10.039 · DOI · Paper page
- Accetta, 2011, Human phagocyte defect caused by a Rac2 mutation detected by means of neonatal screening for T-cell lymphopenia, The Journal of allergy and clinical immunology., 127, 535, 10.1016/j.jaci.2010.10.013 · DOI · Paper page
- Lougaris, 2019, A monoallelic activating mutation in RAC2 resulting in a combined immunodeficiency, The Journal of allergy and clinical immunology., 143, 1649, 10.1016/j.jaci.2019.01.001 · DOI · Paper page
Cited by
Tangye, S. G., Al-Herz, W., Bousfiha, A., Chatila, T., Cunningham-Rundles, C., Etzioni, A., Franco, J. L., Holland, S. M., Klein, C., Morio, T., et al. (2020) · Journal of Clinical Immunology · doi:10.1007/s10875-019-00737-x · Cited by 1,210
Self-citationRHO GTPases: from new partners to complex immune syndromes
El Masri, R., & Delon, J. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00500-7 · Cited by 131
Lagresle-Peyrou, C., Olichon, A., Sadek, H., Roche, P., Tardy, C., Silva, C. D., Garrigue, A., Fischer, A., Moshous, D., Collette, Y., et al. (2020) · Haematologica · doi:10.3324/haematol.2019.230250 · Cited by 35
Clinical and functional spectrum of RAC2-related immunodeficiency
Donkó, Á., Sharapova, S. O., Kabat, J., Ganesan, S., Hauck, F. H., Bergerson, J. R. E., Marois, L., Abbott, J., Moshous, D., Williams, K. W., et al. (2024) · Blood · doi:10.1182/blood.2023022098 · Cited by 32
Self-citationA novel RAC2 variant presenting as severe combined immunodeficiency
Stern, H., Donkó, A., Shapiro, T., Hsu, A. P., Leto, T. L., Holland, S. M., & Andreae, D. A. (2021) · Journal of Clinical Immunology · doi:10.1007/s10875-020-00915-2 · Cited by 15
Self-citationHem1 inborn errors of immunity: waving goodbye to coordinated immunity in mice and humans
Christodoulou, A., Tsai, J. Y., Suwankitwat, N., Anderson, A., & Iritani, B. M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1402139 · Cited by 4
RAC2 orchestrates immune cell actin remodeling and migration
Berthiaume Fox, K. A., Galvin, E. R., Gurtner, G. C., & Chen, K. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1917716
Metadata
- Authors
- Sharapova, S. O., Haapaniemi, E., Sakovich, I. S., Kostyuchenko, L. V., Donkó, A., Dulau-Florea, A., Malko, O., Bondarenko, A. V., Stegantseva, M. V., Leto, T. L., Uygun, V., Karasu, G. T., Holland, S. M., Hsu, A. P., & Aleinikova, O. V.
- Venue
- Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 2019-08
- Volume
- 205
- Pages
- 1-5
- ISSN
- 1521-6616
- Cited by
- 37
- References
- 1
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Funders
- Academy of Finland
- Jeffrey Modell Foundation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.